Ginseng | |||
---|---|---|---|
Scientific name | Synonyms | Common name | Distribution |
Panax ginseng
C.A. Meyer |
Panax pseudoginseng
Wallich;
Panax schinseng Nees | Asian, Chinese, Korean,
or Oriental ginseng 1, , 2 ; red ginseng (steamed) | Northeast China, Korea,
Eastern Siberia |
Panax japonicus
var bipinnatifidus 2 | China | ||
Panax japonicus
C.A. Meyer 2 |
P. pseudoginseng
(Will.) subsp. japonicus | Japanese ginseng
1,
,
2
Chikusetsu ginseng, 3 or zhu je ginseng 4 | India, Southern China, Japan |
P. japonicus
var. major 2 | China | ||
P. notoginseng
(Burkhill) Hoo & Tseng 2 ; ([Buck] F.H. Chen) |
P. pseudoginseng
Wallich var. notoginseng | Western ginseng;
Five-fingers; Sang 2, ; San-chi 1, , 5 ; Tien-chan 1, or tienqi 4 ginseng | Asia |
P. pseudoginseng
subsp. himalaicus | Himalayan ginseng | Nepal | |
P. pseudoginseng
var. major | Zhuzishen | China | |
Panax quinquefolius L. | American or
Canadian ginseng 1, , 6 | Eastern and central
United States and Canada |
|
Panax vietnamensis
Ha et Grushv. | Vietnamese ginseng 1, , 5 | Vietnam |
1. The efficacy of ginseng. Asystematic review of randomised clinical trials . Eur J Clin Pharmacol . 1999 ; ( 8 ): 567-575 . PubMed
, , .2. 1996 : 145-150 .
, , . Herbal Medicines: A Guide for Health-Care Professionals . London: The Pharmaceutical Press;3. Evaluation of the ergogenic properties of ginseng: an update . Sports Med . 2000 ; ( 2 ): 113-133 . PubMed
, , , , .4. Selected herbals and human exercise performance . Am J Clin Nutr . 2000 ; ( 2 suppl ): 624S-636S . PubMed
.5. The antistress effect of majonoside-R2, a major saponin component of Vietnamese ginseng: neuronal mechanisms of action . Methods Find Exp Clin Pharmacol . 1998 ; ( 1 ): 65-76 . PubMed
, , .6. Herbal remedies in psychiatric practice . Arch Gen Psychiatry . 1998 ; ( 11 ): 1033-1044 . PubMed
, , .7. Cold-fX ) . Austin, TX: American Botanical Council; 2007 .
, . Proprietary Phytomedicinal Product Therapeutic Monograph: CVT-E002 (8. 1854 ; : 231 .
. Ann Chem Pharm .9. Pharmacological investigation of glycosides from ginseng and eleutherococcus . Lloydia . 1969 ; ( 1 ): 46-51 . PubMed
, .10. Two glycoside-containing genera of the Araliaceae family Panax and Eleutherococcus . Planta Med . 1973 ; ( 4 ): 392-396 . PubMed
.11. Seasonal variation of saponins, sucurose and monosaccharides in cultivated ginseng roots . Planta Med . 1981 ; ( 6 ): 181-186 . PubMed
, , , , , .12. 1980 ; : 340 .
, et al. J Nat Prod .13. Comparative clinical studies on ginseng drugs [in German]. Arch Pharm Ber Dtsch Pharm Ges . 1967 ; ( 4 ): 371-183 . PubMed
, .14. 1997 : 37-38 .
. Popular Herbs in the U.S. Market. Ginseng root (Asian) . Austin, TX: American Botanical Council;15. 1997 .
, , , , , eds. Klein, Rister R, trans. German Commission E Monographs: Therapeutic Monographs on Medicinal Plants for Human Use . Austin, TX: American Botanical Council;16. HPLC separation and quantitative determination of ginsenosides from Panax ginseng , Panax quinquefolium and from ginseng drug preparations. 2nd communication . Planta Med . 1980 ; ( 4 ): 348-357 . PubMed
, .17. A comparative study on commercial samples of ginseng radix . Planta Med . 1995 ; ( 5 ): 459-465 . PubMed
, , , , , .18. Evaluation of commercial ginseng products . J Pharm Sci . 1978 ; ( 10 ): 1487-1489 . PubMed
, .19. Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone . JAMA . 1975 ; : 352 . PubMed
, et al.20. Toxic reactions to plant products sold in health food stores . Med Lett Drugs Ther . 1979 ; : 29 . PubMed
21. Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Metabolic activation of ginsenoside: Deglycosylation by intestinal bacteria and esterification with fatty acid . J Pharmacol Sci . 2004 ; : 153-157 . PubMed
.22. Effect of ginseng saponins and hydrocortisone on phytohemagglutinin transformation of lymphocytes . Lancet . 1982 ; ( 8299 ): 663-664 . PubMed
, , , .23. Immunomodulatory activity of Panax ginseng extract . Planta Med . 1984 ; ( 6 ): 462-465 . PubMed
, , .24. No adaptogen response of mice to ginseng and eleutherococcus infusions . J Ethnopharmacol . 1983 ; ( 2 ): 209-214 . PubMed
, , .25. Effect of American ginseng extract ( Panax quinquefolius ) on formalin-induced nociception in mice . Am J Chin Med . 2001 ; ( 1 ): 149-154 . PubMed
, , , .26. Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng ( Panax quinquefolium ) . J Pharm Pharmacol . 2001 ; ( 11 ): 1515-1523 . PubMed
, , , et al.27. Natural health products, modulation of immune function and prevention of chronic diseases . Evid Based Complement Alternat Med . 2005 ; ( 4 ): 513-520 . PubMed
, , , .28. A proprietary extract from North American ginseng ( Panax quinquefolium ) enhances IL-2 and IFN-gamma productions in murine spleen cells induced by Con-A . Int Immunopharmacol . 2004 ; ( ): 311-315 .
, , , et al.29. The immunological-base of a North American Ginseng Extract, Cold-fX for prevention of colds and flu . J Complement Integrat Med . 2005 ; : 28 .
.30. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults . J Am Geriatr Soc . 2004 ; ( 1 ): 13-19 .
, , , et al.31. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial . CMAJ . 2005 ; ( 9 ): 1043-1048 . PubMed
, , , , , .32. Efficacy of Cold-Fx , a natural health product in the prevention of recurrent upper respiratory tract infections in a susceptible population: a randomized, double-blind, placebo controlled trial . J Complement Integrat Med . 2005 ; ( 1 ): 28 .
, , , , .33. Immune modulating effects of daily supplementation of Cold-fX (a proprietary extract of North American ginseng) in healthy adults . J Clin Biochem Nutr . 2006 ; ( 3 ): 160-165 .
, , , .34. Efficacy of Cold-fX in the prevention of respiratory symptoms in community-dwelling adults: A randomized, double-blinded, placebo-controlled trial . J Altern Complement Med . 2006 ; ( 2 ): 153-157 . PubMed
, , , , .35. Ginseng pharmacology, multiple constituents and multiple actions . Biochem Pharmacol . 1999 ; ( 11 ): 1685-1693 . PubMed
, , .36. Pharmacological and physiological effects of ginseng on actions induced by opioids and psychostimulants . Methods Find Exp Clin Pharmacol . 1998 ; ( 1 ): 77-84 .
, .37. Vascular effects of selected antihypertensive drugs derived from traditional medicinal herbs . Clin Exp Pharmacol Physiol . 1995 ; ( 1 ): S297-S299 . PubMed
.38. Cardiovascular protection by ginsenosides and their nitric oxide releasing action . Clin Exp Pharmacol Physiol . 1996 ; ( 8 ): 728-732 .
.39. Ginseng therapy in non-insulin-dependent diabetic patients . Diabetes Care . 1995 ; ( 102 ): 1373-1375 . PubMed
, , .40. American ginseng ( Panax quinquefolius L.) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus . Arch Intern Med . 2000 ; ( 7 ): 1009-1013 . PubMed
, , , et al.41. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes . Diabetes Care . 2000 ; ( 9 ): 1221-1226 . PubMed
, , , , , , .42. Ginseng treatment improves psychomotor performance at rest and during graded exercise in young athletes . Int J Sport Nutr . 1999 ; ( 4 ): 371-377 . PubMed
, , , , , .43. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers . J Ethnopharmacol . 1986 ; ( 1 ): 15-22 .
, , , et al.44. Effects of CVT-E002, a proprietary extract from the North American ginseng ( Panax quinquefolium ) on hepatic drug-metabolizing enzymes in C57BL/6J mice . J Chin Med . 2002 ; ( 2 ): 89-96 .
, .45. Inhibition of human hepatic cytochrome P450 enzymes by Cold-fX and Remember-fX proprietary extracts of North American ginseng ( Panax quinquefolium ) . J Complement Integrat Med . 2005 ; ( 1 ): 28 .
, .46. Ginseng-induced diuretic resistance . JAMA . 1996 ; ( 8 ): 606-607 . PubMed
, , , , .47. An open trial of nifedipine-herb interactions: nifedipine with St. John's wort, ginseng or Ginkgo biloba . Clin Pharmacol Ther . 2001 ; : P86 .
, et al.48. Phenelzine and the dream machine - ramblings and reflections . J Clin Psychopharmacol . 1985 ; ( 2 ): 65 .
, .49. Interaction of ginseng with phenelzine . J Clin Psychopharmacol . 1987 ; ( 3 ): 201-202 . PubMed
, .50. Probable interaction between warfarin and ginseng . Am J Health Syst Pharm . 1997 ; ( 6 ): 692-693 . PubMed
, .51. Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product . Cardiology . 2003 ; ( 2 ): 111 . PubMed
.52. Effect of St. John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects . Br J Clin Pharmacol . 2004 ; 7( 5 ): 592-599 . PubMed
, , , et al.53. Oestrogen-like effect of ginseng . Br Med J . 1980 ; ( 6248 ): 1110 . PubMed
, .54. Gin Seng and mastalgia . Br Med J . 1978 ; ( 6122 ): 1284 . PubMed
, , .55. Ginseng and vaginal bleeding . JAMA . 1983 ; ( 15 ): 2018 . PubMed
.56. Adverse reactions to ginseng . Med J Aust . 1981 ; ( 9 ): 492 . PubMed
, .57. Doping-control urinalysis of a ginseng extract, Cold-fX , in athletes . Int J Sport Nutr Exerc Metab . 2004 ; ( 4 ): 473-480 . PubMed
, , , , .